Birth Control Implant Market 2019-2025
New Market Study, Report “Birth Control Implant Market 2019 Global Market Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2025” Has been Added on WiseGuyReports.com.
The global Birth Control Implant market is estimated at $ 15.6 billion in 2018 and is expected to increase by 3.8% over the forecast period. Raising awareness of preventive practices in developing economies, investing key actors in developing innovative devices, and supporting government initiatives to improve access to products are critical directions for accelerating growth.
Partnership and cooperation in research, development, and marketing of new products are some of the key tactics adopted by the key players to increase market share. For example, Medicines 360 and Allergan announced their collaboration with medical centers to help solve unwanted pregnancy problems in dangerous areas like Puerto Rico and Florida in February 2017. The partnership helped expand access to the Birth Control Implant system. Of levonorgestrel, a company in the area LILETTA contraception for up to three years.
Information programs for governments and market participants increase demand and hence, the prevention market. For example, in July 2015, Teva Pharmaceutical Industries launched an “absolutely perfect” educational initiative to raise awareness about emergency contraception. Also, in September 2015, Allergan announced its collaboration with the US Women’s Health Alliance (USWHA), an organization that promotes high-quality, affordable women’s health services. This agreement will provide LILETTA, the intrauterine allergic system, to women in the USWHA group.
The Birth Control Implant market is fragmented due to the presence of several generators. The leading players are Allergan. Afaxys, Inc. Teva Pharmaceutical Industries Ltd.; Bayer AG; Soup Co., Ltd.; Agile Pfizer Treatments. And Apothecus Pharma Corporation.
Request for Free Sample Report of “Birth Control Implant” Market @ https://www.wiseguyreports.com/sample-request/4504467-global-birth-control-implant-market-professional-survey-report-2019
The introduction of long-term reversible devices is a crucial driver of market growth. For example, in September 2016, Bayer Inc. The new Kyleena Intrauterine System (IUS) birth control system. The release of Kyla is expected to help meet the need for long-term contraception in women under five.
Factors affecting growth prospects
Based on this method, the Birth Control Implant market is divided into tablets, intrauterine devices, injectable drugs, vaginal rings, implantation, and repair. In 2018, birth control pills accounted for the largest market share. It should preserve its scope during the forecast period. The growth of the sector can be explained by simple and straightforward management, ease of availability of a wide range of products, high awareness of tablets due to early market entry versus device operation over time. Moreover, the presence of different and diverse market players in the region and the increased penetration of developing countries may contribute to the growth of the sector.
North America led the global market in 2018 and is expected to maintain its position during the forecast period. This may be due to high per capita income, a strong presence of key market players, increased awareness of sexual health, and a large number of unwanted pregnancies. An increasing number of product launches, positive government initiatives, and public awareness are expected to help drive the Middle East and Africa markets. For example, in May 2013, Merck & Co and its public sector partners expanded an agreement to expand access to Impson. Under the contract, the company expects to reduce implant prices and the new generation of Implanon NXT (etonogestrel) by about 50% over the next six years in 70 developing countries.
Birth Control Implant Manufacturers
Birth Control Implant Distributors/Traders/Wholesalers
Birth Control Implant Subcomponent Manufacturers
If you have any special requirements, please let us know and we will offer you the report as you want.
The Asia-Pacific region expects the fastest growth over the forecast period. Significant factors that complement Birth Control Implant regional growth are the presence of a sizable fertile population, the introduction of new female contraceptives, increased investment by market participants, and steady economic growth.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)